Merit Medical Systems (NASDAQ:MMSI) is set to post its quarterly earnings results after the market closes on Wednesday, April 25th. Analysts expect Merit Medical Systems to post earnings of $0.29 per share for the quarter. Merit Medical Systems has set its FY18 guidance at $1.57-1.69 EPS.
Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Wednesday, February 28th. The medical instruments supplier reported $0.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.32 by $0.01. Merit Medical Systems had a return on equity of 9.65% and a net margin of 3.78%. The company had revenue of $190.90 million during the quarter, compared to analysts’ expectations of $187.62 million. During the same quarter in the prior year, the business posted $0.31 earnings per share. The company’s revenue for the quarter was up 21.0% compared to the same quarter last year. On average, analysts expect Merit Medical Systems to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
NASDAQ:MMSI opened at $45.80 on Wednesday. Merit Medical Systems has a 1 year low of $28.13 and a 1 year high of $49.50. The firm has a market capitalization of $2,264.67, a PE ratio of 35.78, a price-to-earnings-growth ratio of 2.07 and a beta of 1.29. The company has a quick ratio of 1.39, a current ratio of 2.73 and a debt-to-equity ratio of 0.38.
ILLEGAL ACTIVITY WARNING: “Merit Medical Systems (MMSI) to Release Earnings on Wednesday” was originally posted by Week Herald and is owned by of Week Herald. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://weekherald.com/2018/04/18/merit-medical-systems-mmsi-to-release-earnings-on-wednesday.html.
About Merit Medical Systems
Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.